































Maternal diet and the developmental origins of type 
2 diabetes 
 
It is well established that what we eat has a major 
impact on our health. However, there is growing 
evidence to suggest that diet during pregnancy and 
lactation may be particularly important as not only does 
it influence the health of the mother, it may have a 
permanent effect on the health of her children and even 
her grandchildren. The concept that environmental 
factors, such as nutrition during early development, 
influence both our health span and lifespan has been 
termed the developmental origins of health and disease 
hypothesis [1]. Focus on this possibility was prompted 
by the results of a series of epidemiological studies that 
revealed relationships between patterns of early growth 
and long-term risk of metabolic conditions such as type 2 
diabetes (T2D) and cardiovascular disease [1]. Initial 
studies demonstrated that there was a linear relationship 
between birth weight and prevalence of these conditions 
in later life, with individuals with the lowest birth 
weight being around six times  more likely to have  T2D  
 
 































than those with the highest birth weight [2]. These 
associations have been replicated in numerous 
populations worldwide representing multiple ethnic 
groups, though those in some of the more contemporary 
cohorts where there was a high prevalence of maternal 
obesity also revealed an increased risk of metabolic 
disease in the very high birth weight offspring [3]. 
Subsequent studies demonstrated that the detrimental 
effects of being born small for gestational age were 
exaggerated if an individual grew rapidly in early 
postnatal life [4]. It was also demonstrated that 
accelerated postnatal growth, independently of growth 
in utero, increased the risk of metabolic conditions such 
as obesity [5]. 
 
Observational studies linking patterns of early growth 
with long-term health don’t provide proof that 
suboptimal nutrition mediates these relationships. 
However studies in human cohorts and in animal 
models have provided strong evidence that 
environmental factors, including nutrition, play an 
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mediating the relationships between birth weight and 
long-term health has come from the study of 
monozygotic (identical) twins. These studies revealed 
that in monozygotic twin pairs discordant for T2D, the 
diabetic twin has a lower birth weight than their non-
diabetic co-twin [6, 7] Assessing the role of maternal 
diet in mediating the relationships between fetal growth 
and long-term health in a human context is complex. 
However, studies of individuals in utero during periods 
of famine have shown direct relationships between 
severe maternal nutrient deficiency and increased risk of 
T2D in the offspring [8, 9]. The importance of neonatal 
nutrition for long-term health has been demonstrated 
very clearly in human studies. Initial observational 
studies demonstrated the protective effects of breast-
feeding on future risk of metabolic disease [10] and 
subsequent randomized intervention studies revealed 
causal relationships between nutrition during early 
postnatal life and long-term metabolic health [11]. 
Animal models have provided compelling evidence that 
maternal diet during pregnancy and lactation influence 
long-term health including risk of T2D, obesity, 
hypertension and cardiovascular disease. The 
developmental origins of health and metabolic disease 
is therefore widely accepted. 
 
Interaction between maternal diet and aging in T2D 
risk 
 
Most conditions associated with patterns of early 
growth and nutrition are diseases associated with aging. 
Therefore, perhaps not too surprisingly, the small size at 
birth has been associated with increased mortality in 
humans. In a large Finnish study a low birth weight was 
associated with increased mortality at all ages in women 
and with premature death (< age 55) in men [12]. 
Studies in rodent models have also shown direct 
associations between maternal diet and lifespan of the 
offspring [13, 14]. Maternal protein restriction during 
pregnancy resulting in low birth weight, followed by 
postnatal catch-up growth through suckling by normally 
fed dams (recuperated offspring) led to a reduction in 
lifespan. In contrast, maternal protein restriction and 
slow growth during the lactation period resulted in 
increased life span and conferred protection from the 
detrimental effects of an obesogenic diet. In addition to 
differences in aging at the whole body level, these same 
rodent models have revealed effects of maternal diet on 
aging at the cellular level, as demonstrated by 
differences in rates of telomere shortening and in 
markers of cellular senescence [15].  
 
The islets of Langerhans in the endocrine pancreas, the 
only cells in the body that can produce insulin, appear 
to be particular vulnerable to the detrimental effects of 
maternal diet on their aging trajectory. This is consistent 
with the early environment having a major influence on 
regulation of glucose homeostasis and consequently 
diabetes risk. Some of the earliest effects on telomere 
shortening resulting from maternal protein restriction 
are observed in pancreatic islets and this is accompanied 
by premature induction of p16, one of the most robust 
biomarkers of aging [15]. In addition, maternal protein 
restriction during pregnancy and lactation results in 
increased age-associated oxidative stress and 
development of fibrosis [16].   
 
The molecular bases of the interaction between 
maternal diet, aging and the risk for T2D are currently 
poorly understood. However, the hypothesis that this 
interaction could be mediated by epigenetic 
mechanisms offers an attractive explanation for the link 
between nutrition, regulation of gene expression, and 
the risk for disease (Figure 1). 
 
Epigenetic dynamics during early development and 
aging 
 
Gene transcription is the result of the interactions 
between transcription factors and chromatin at a number 
of genomic regulatory elements including promoters, 
enhancers, insulators and silencers. Accessibility to 
these sites is mediated by epigenetic modifications of 
histones and DNA. It is widely accepted, for example, 
that upon histone acetylation, genes become actively 
transcribed, whereas deacetylation leads to repression. 
Modifications of the DNA itself, such as methylation 
and most recently hydroxymethylation, are also 
important indicators of the transcriptional regulatory 
activity of many genomic loci.  
 
Epigenetic marks are responsive to environmental and 
developmental cues, as there is a need to modify the 
transcriptional outputs of genes throughout the life of an 
organism [17, 18]. It is clear that chromatin structure 
changes in response to the cell’s many stimuli. Certain 
epigenetic marks can be added and removed before a 
cell divides or within few cell divisions. Such short-
term flexibility is particularly important to allow 
appropriate responses to acute environmental cues. 
Other epigenetic marks can be maintained for many cell 
divisions. Long-term stability is required for epigenetic 
programming of the early embryo, a process that refers 
to the acquisition and stable propagation of marks that 
define cell types
 and maintain cellular memory [18]. 
 
Deregulation of epigenetic processes with age is a 
common feature in mammals [19]. Widespread and 
tissue-specific  age-related  DNA  methylation   changes  
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[20]. It is also becoming increasingly clear that diseases 
associated with aging, such as T2D, may have an 
important epigenetic component [18, 21]. However, 
little is known about the interactions between 
environmental exposures, aging and epigenetic variation 

















































Regulation of promoter-enhancer interactions as a 
novel epigenetic mechanism by which maternal diet 
and aging influence long-term health 
 
A recent study in rats sheds novel insights on the 
epigenetic mechanisms by which environmental 
exposures can increase the risk of T2D [22]. Sandovici 
and co-workers used a well-established model for the 
developmental origins of T2D to study the interaction 
between early life sub-optimal nutrition, aging and 
epigenetic states at a locus encoding a key transcription 
factor: HNF4-α. Rats exposed to a low protein (LP) 
maternal diet during gestation and lactation showed 
reduced Hnf4a transcription at a young age (3 months, 
3M) that persisted throughout life when compared to 
normally fed controls. LP offspring develop T2D at old 
age (17M), whereas normally fed controls rarely do so. 
The authors showed that the reduced Hnf4a expression 
observed at a young age was made permanent 
throughout life and aging, via the stable maintenance of 
repressive epigenetic marks. Remarkably, the early-diet 
epigenetic silencing effects were targeted to a regulatory 
element distal to the active promoter – an enhancer 
element. The abnormal epigenetic marking weakened 
the physical interaction with the upstream promoter and 
resulted in reduced expression of the gene. 
Interestingly, the accumulation of the repressive marks 
were more pronounced in aged rats that were exposed to 
a sub-optimal diet in early life than those exposed to a 
normal diet, which is suggestive of an interaction 
between early-nutrition and aging effects at this locus. 
Down-regulation of Hnf4a  has been found in T2D 
patients [23] and genetic polymorphisms within or 
nearby this gene are associated with T2D risk [24]. The 
sustained lifelong reduction of Hnf4a resulting from de-
regulation of an epigenetically controlled enhancer-
promoter interaction is thus likely to contribute to the 
T2D effects in this model. This work is relevant to 
human T2D risk, as the epigenetic mechanisms that 
regulate Hnf4a in rats are highly conserved in human 
islets [22].  
 
Several HNF-4α protein variants can arise from mRNAs 
transcribed from two promoters, proximal P1 and distal 
P2, however, in islets only the P2 promoter is active. An 
enhancer region is located upstream of the P1 promoter 
and downstream of the P2 promoter (Figure 2A). This 
shared enhancer increases the activity of both promoters 
in a tissue-specific manner. In islets, the chromatin 
configuration of the P1 promoter differs dramatically 
from that of the P2 promoter and the enhancer region. 
Accordingly, P1 is enriched in histone repressive marks 
and has high levels of DNA methylation, leading to 
closed chromatin, whereas the P2 promoter and the 
enhancer are  characterized  by open  chromatin  (Figure  
Figure 1. The role of maternal diet in the development‐
tal origins of metabolic disease. An abnormal diet during
pregnancy  can  induce  gene  expression  changes  in  the
developing fetus. These changes are then perpetuated during
many  subsequent  rounds  of  cell  division  throughout  the
lifetime  of  the  offspring  (cell  memory)  and  may  lead  to  an
increased disease risk in the adulthood.  
   


















































2A). This epigenetic pattern dictates the activity of the 
promoters, with P2 being the active one in islets (Figure 
2A). The effects of early life exposure to a maternal LP 
diet were specific to the enhancer region – with 
recruitment of the repressive mark H3K9me2 and loss 
of a mark predictive of active enhancers, H3K4me1 
(Figure 2B). In turn, aging led to widespread epigenetic 
silencing across the locus (Figure 2C). Most 
prominently, the Polycomb-dependent histone 
repressive mark H3K27me3 was found enriched at the 
P2 and the enhancer regions with age. In this study, 
causality effects of the epigenetic marking on 
transcription levels were inferred through 
pharmacological inhibition of specific histone 
modifications and of DNA methylation in insulin-
secreting cell lines. 
 
The work by Sandovici et al. provides novel insights 
into the epigenetic deregulation during aging and the 
associated decline in function of the endocrine pancreas. 
Hnf4a levels decline with age, an effect that was 
associated with recruitment of the Polycomb-mediated 
histone repressive mark H3K27me3. Repression by 
H3K27me3 across the P2 and enhancer regions was 
greater in magnitude in rats fed a sub-optimal LP 
maternal diet compared to controls. This finding raises 
several questions: does age-related H3K27me3 
repression occur earlier in LP rats compared to controls, 
which would be indicative of premature epigenetic 
“aging” at this locus? Do H3K27me3 levels contribute 
to the age-associated increased risk for diabetes? (LP 
rats, with higher enrichment of H3K27me3 develop 
diabetes, whereas control rats with lower levels of 
H3K27me3 are diabetes-free) Is age-related Polycomb-
mediated accumulation of H3K27me3 associated with 
repression of other key diabetes genes in islets?  
 
Prior to the work by Sandovici et al. there was only one 
published report analysing the effects of early life-
events on epigenetic states during aging [25]. In this 
study, a daily 3 hour separation of mouse pups from 
their mother during postnatal days 1-10 caused 
persistent hypomethylation at specific CpG sites of the 
arginine vasopressin (Avp) gene enhancer at 6 weeks of 
age, with age-associated hypomethylation (at 1 year of 
age) occurring stochastically across the entire Avp locus 
[25].  The study by Sandovici et al. similarly shows that 
early-life epigenetic changes are targeted towards 
important regulatory elements, while age-associated 
effects are widespread and likely stochastic. However, 
in contrast to the Avp study, the differential changes in 
epigenetic states at the Hnf4a locus in response to early-
life events and aging seem to be mechanistically and 
functionally linked. Indeed, whilst the age-associated 
hypomethylation of the Avp had no effect on mRNA 
expression levels, Hnf4a repression by histone 
modifications with age resulted in lower levels of 
expression. Furthermore, the early-diet induced 
epigenetic programming effects at the enhancer were 
largely maintained during aging, and were even more 
Figure  2.  Model  of  epigenetic  control  at  the  Hnf4a
locus.  (A)  In  young  control  islets  the  P2  promoter  has  low
levels  of  DNA  methylation  and  is  associated  with  open
chromatin and high levels of transcription (enrichment in H3Ac
and H3K4me3). An active downstream enhancer (enriched in
H3Ac  and  H3K4me1)  is  essential  for  high  levels  of  P2
transcription.  Accessibility  of  transcription  factors  to  the  P1
promoter is blocked by DNA methylation and H3K9me2. (B)
Down‐regulation  of  P2  transcriptional  activity  in  young  LP
islets  results  from  loss  of  enhancer  activity.  The  enhancer
adopts a closed chromatin configuration with enrichment in
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H3K27me3. Therefore, the aging process did not 
disrupt the long-lasting programming effects at this 
locus and may have instead amplified its effects. 
 
The work by Sandovici et al. showed that 
environmental stimuli could induce specific changes in 
epigenetic states at an enhancer region and provided 
insights into the mechanisms by which transcript levels 
were altered. By using the chromatin conformation 
capture (3C) technology the study identified a stable P2 
promoter-enhancer interaction in islets that determines 
the establishment of a functional expression domain 
(Figure 3). This interaction was much weaker in islets 
isolated from LP offspring (Figure 2) and in insulin-
secreting cell lines, both of which have low levels of P2 
transcripts, as well as in liver, a tissue that does not 





































enhancer interaction is likely to be primarily mediated 
by the epigenetic state of the enhancer, i.e. a closed 
configuration by recruitment of repressive marks leads 
to a weaker interaction (Figure 3). If this is true, one 
could extrapolate that the P2 promoter-enhancer 
interaction in islets will be weaker with aging (Figure 
3), although this hypothesis has not been experimentally 
tested. On the basis of this model Sandovici et al. 
proposed that the epigenetic control of the P2-enhancer 
interactions in islets underpins the sustained changes in 
Hnf4a  expression levels, which influence in turn the 
risk for the age-associated T2D. It is tempting to 
speculate that this model could also provide a 
mechanistic understanding of how polymorphisms 
within the human Hnf4a locus may increase T2D risk, 
as the genetic sequence, in addition to the epigenotype, 








































Figure  3.  Proposed  simplified  model  for  the  enhancer‐promoter  looping  at  the
Hnf4a locus in young and old C and LP islets. In islets from young adult C rats the





marks  across  the  locus,  which  is  more  pronounced  in  LP  islets.  The  accumulation  of
suppressive histone marks might further weaken the P2 promoter‐enhancer interaction. 
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The findings by Sandovici et al. led to the proposal that 
altered epigenetic control of enhancer-promoter 
interactions are crucial for establishing long-lasting 
programming and aging effects. The catalogue of 
environmentally-induced epigenetic modifications that 
affect enhancers is still rather limited, including so far 
the Avp enhancer mentioned above [25], Ppara [26] and 
now  Hnf4a [22]. Using genome-wide unbiased 
approaches to identify cell-type specific chromatin 
signatures at enhancer regions during early-life 
programming and aging has the potential to define 
many more. Indeed, efforts to identify regulatory 
elements, i.e. enhancers, repressors and insulators, are 
now well underway taking advantage of the 
advancement of genome-wide approaches [27-29]. One 
such study performed in human cell lines suggests the 
existence of a vast number of enhancers in the genome, 
in the order of 10
5-10
6, that are used to drive specific 
gene expression patterns in the estimated 200 cell types 
of the human body [28]. Results from this study suggest 
that enhancers are the most variable class of 
transcriptional regulatory elements between cell types in 
terms of epigenetic signatures. On the contrary, the 
chromatin states at promoters and the CTCF binding at 
insulators were found to be largely invariant across 
diverse cell types [28]. The effects of early-life adverse 
effects and aging on enhancer-promoter interactions 
and, more widely, on long-range genomic interactions 
[30, 31] is a promising area of future research that may 
add important insights to our understanding of the 
underlying mechanisms of age-associated diseases, and 
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